Korea hypertension fact sheet 2018

被引:77
作者
Jeong J.-W.
Shin G.
Kim D.S.
Kim G.-H.
Kang S.-M.
Pyun W.B.
Lee H.-Y.
Chung W.-J.
Ihm S.-H.
Kim K.I.
Cho E.J.
Sohn I.-S.
Park S.
Shin J.
Sung K.C.
Ryu S.K.
Sung J.
Kim D.J.
Ryu D.-R.
Yang D.H.
Yoo B.S.
Rhee M.-Y.
Lee S.H.
Lee E.M.
Chung J.H.
Jeong J.O.
Han J.
Hong Y.M.
Hwang J.Y.
Park C.G.
Rim S.-J.
Ahn S.V.
Jee S.H.
Shin M.H.
Park J.K.
Suh I.
Lee T.-Y.
Lee S.W.
Kim H.C. [1 ]
Cho M.-C. [2 ]
机构
[1] Department of Preventive Medicine, Yonsei University, College of Medicine, Seoul
[2] Department of Internal Medicine, Chungbuk National University, College of Medicine, Cheongju
关键词
Anti-hypertensive medication; Awareness; Control; Hypertension; Korea; Prevalence; Treatment;
D O I
10.1186/s40885-018-0098-0
中图分类号
学科分类号
摘要
Background: The Korea Hypertension Fact Sheet 2018 aims to overview the magnitude and management status of hypertension, and their trends in Korea. Methods: The Hypertension Epidemiology Research Group analyzed the 1998-2016 Korea National Health and Nutrition Examination Survey data and the 2002-2016 Korea National Health Insurance Big Data. Results: The population average of systolic/diastolic blood pressure was 118/77 mmHg among Korean adults (age 30+) in 2016, showing little change in recent 10 years. However, the number of people with hypertension increased steadily, exceeding 11 million. The number of people diagnosed with hypertension increased from 3 million in 2002 to 8.9 million in 2016. The number of people using antihypertensive medication increased from 2.5 million in 2002 to 8.2 million in 2016. However, only 5.7 million people are being treated constantly. Hypertension awareness, treatment, and control rates increased fast until 2007, but showed a plateau thereafter. More than half of the young hypertensive patients (30-49 years) did not know about and treat for their hypertension. Among patients prescribed antihypertensive medications, 45% was elderly people over the age of 65 years, 57% used anti-diabetic or cholesterol-lowering medications, and 60% were prescribed two or more class of antihypertensive medications simultaneously. Conclusions: In Korea, the level of hypertension management has considerably improved over the last 20 years. In order to achieve further improvement in hypertension management status, we need to find the vulnerable subgroups and develop subgroup-specific intervention strategies. It is also becoming more important to manage hypertensive patients at older age and those with concurrent chronic diseases. © 2018 The Author(s).
引用
收藏
相关论文
共 8 条
[1]  
Lopez A.D., Mathers C.D., Ezzati M., Jamison D.T., Murray C.J., Global and regional burden of disease and risk factors, 2001: Systematic analysis of population health data, Lancet, 367, pp. 1747-1757, (2006)
[2]  
Feigin V.L., Et al., Global burden of stroke and risk factors in 188 countries, during 1990-2013: A systematic analysis for the global burden of disease study 2013, Lancet Neurol, 15, pp. 913-924, (2016)
[3]  
Levenson J.W., Skerrett P.J., Gaziano J.M., Reducing the global burden of cardiovascular disease: The role of risk factors, Prev Cardiol, 5, pp. 188-199, (2002)
[4]  
Lee K., Park J., Burden of disease in Korea during 2000-10, J Public Health, 36, pp. 225-234, (2013)
[5]  
2015. National Health Insurance Corporation
[6]  
Lee S.W., Et al., Status of hypertension screening in the Korea National General Health Screening Program: A questionnaire survey on 210 screening centers in two metropolitan areas, Clin Hypertens, 23, (2017)
[7]  
Kweon S., Et al., Data resource profile: The Korea national health and nutrition examination survey (KNHANES), Int J Epidemiol, 43, pp. 69-77, (2014)
[8]  
Seong S.C., Et al., Data resource profile: The national health information database of the National Health Insurance Service in South Korea, Int J Epidemiol, 46, pp. 799-800, (2016)